Estimating hepatic glucokinase activity using a simple model of lactate kinetics

Diabetes Care

Volumn 35, Issue 5, 2012, Pages 1015-1020

  Stefanovski, Darko ^a   Youn, Jang H ^a   Rees, Matthew ^b   Watanabe, Richard M ^a   Ader, Marilyn ^a   Ionut, Viorica ^a   Jackson, Anne U ^c   Boehnke, Michael ^c   Collins, Francis S ^b   Bergman, Richard N ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; LACTIC ACID; TOLBUTAMIDE;

ADULT; ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; FINLAND; GLUCOSE HOMEOSTASIS; GLUCOSE KINETICS; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; KINETICS; LACTATE BLOOD LEVEL; LACTIC KINETICS; LIVER; MALE; UNITED STATES;

ANIMALS; GLUCOKINASE; GLUCOSE TOLERANCE TEST; GLYCOLYSIS; HUMANS; LACTIC ACID; LIVER; MODELS, THEORETICAL;

EID: 84862061974     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1540     Document Type: Article

References (37)

1. Matschinsky FM, Porte D. Glucokinase activators (GKAs) promise a new pharmacotherapy for diabetics. F1000 Med Rep 2010;2:43
2. Dupuis J, Langenberg C, Prokopenko I, et al.; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-116
3. Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 2010;42:684-687
4. Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN. Portal glucose infusionglucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal. Am J Physiol Endocrinol Metab 2010;298:E346-E353
5. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-E677 (Pubitemid 9220487)
6. Watanabe RM, Valle T, Hauser ER, et al. Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 1999;49:159-168 (Pubitemid 29261381)
7. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 2008;414:1-18
8. Valle T, Tuomilehto J, Bergman RN, et al. Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) study. Diabetes Care 1998;21:949-958 (Pubitemid 28488787)
9. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 1993;42:250-256 (Pubitemid 23045028)
10. Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 1990;39:647-652 (Pubitemid 20218960)
11. Katz J, McGarry JD. The glucose paradox. Is glucose a substrate for liver metabolism? J Clin Invest 1984;74:1901-1909 (Pubitemid 15197330)
12. Terauchi Y, Takamoto I, Kubota N, et al. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 2007;117:246-257 (Pubitemid 46048470)
13. Solera J, Arias P, Amiñoso C, et al. Identification of eight new mutations in the GCK gene by DHPLC screening in a Spanish population. Diabetes Res Clin Pract 2009;85:20-23
14. Njølstad PR, Søvik O, Cuesta-Muñoz A, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001;344:1588-1592 (Pubitemid 32479911)
15. Gu Y, Mao Y, Li H, et al. Long-term renal changes in the liver-specific glucokinase knockout mouse: implications for renal disease in maturity-onset diabetes of the young 2. Transl Res 2011;157:111-116
16. Wagenknecht LE, Palmer ND, Bowden DW, et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011;31:412-416
17. Black MH, Fingerlin TE, Allayee H, et al. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 2008;57:1048-1056
18. Watanabe RM, Lovejoy J, Steil GM, DiGirolamo M, Bergman RN. Insulin sensitivity accounts for glucose and lactate kinetics after intravenous glucose injection. Diabetes 1995;44:954-962
19. Bergman RN, Cobelli C. Minimal modeling, partition analysis, and the estimation of insulin sensitivity. Fed Proc 1980;39:110-115 (Pubitemid 10146127)
20. Edgerton DS, Cardin S, Neal D, et al. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog. Am J Physiol Endocrinol Metab 2004;286:E510-E522 (Pubitemid 38374947)
21. Chen G, Zhang Y, Lu D, Li N-Q, Ross AC. Retinoids synergize with insulin to induce hepatic GCK expression. Biochem J 2009;419:645-653
22. Coghlan M, Leighton B. Glucokinase activators in diabetes management. Expert Opin Investig Drugs 2008;17:145-167 (Pubitemid 351578197)
23. Kuwajima M, Golden S, Katz J, Unger RH, Foster DW, McGarry JD. Active hepatic glycogen synthesis from gluconeogenic precursors despite high tissue levels of fructose 2,6-bisphosphate. J Biol Chem 1986;261:2632-2637 (Pubitemid 17218274)
24. Newgard CB, Hirsch LJ, Foster DW, McGarry JD. Studies on the mechanismby which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? J Biol Chem 1983;258:8046-8052 (Pubitemid 13075272)
25. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 1998;47:523-529 (Pubitemid 28160440)
26. Shulman GI, Cline G, Schumann WC, Chandramouli V, Kumaran K, Landau BR. Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. Am J Physiol 1990;259:E335-E341 (Pubitemid 20320755)
27. Soares AF, Viega FJ, Carvalho RA, Jones JG. Quantifying hepatic glycogen synthesis by direct and indirect pathways in rats under normal ad libitumfeeding conditions. Magn Reson Med 2009;61:1-5
28. Jungermann K. Functional significance of hepatocyte heterogeneity for glycolysis and gluconeogenesis. Pharmacol Biochem Behav 1983;18(Suppl. 1):409-414 (Pubitemid 14122321)
29. Connett RJ, Honig CR, Gayeski TE, Brooks GA. Defining hypoxia: a systems view of VO2, glycolysis, energetics, and intracellular PO2. J Appl Physiol 1990;68:833-842 (Pubitemid 20136403)
30. Connett RJ, Gayeski TE, Honig CR. Lactate accumulation in fully aerobic, working, dog gracilis muscle. Am J Physiol 1984;246:H120-H128 (Pubitemid 14147897)
31. van Hall G. Lactate kinetics in human tissues at rest and during exercise. Acta Physiol (Oxf) 2010;199:499-508
32. Davis MA, Williams PE, Cherrington AD. Effect of amixed meal on hepatic lactate and gluconeogenic precursor metabolism in dogs. Am J Physiol 1984;247:E362-E369 (Pubitemid 14006447)
33. Menzies P, Menzies C, McIntyre L, Paterson P, Wilson J, Kemi OJ. Blood lactate clearance during active recovery after an intense running bout depends on the intensity of the active recovery. J Sports Sci 2010;28:975-982
34. Beneke R, Hütler M, Jung M, Leithäuser RM. Modeling the blood lactate kinetics at maximal short-term exercise conditions in children, adolescents, and adults. J Appl Physiol 2005;99:499-504
35. Santos ICR, Frigeri HR, Réa RR, et al. The glucokinase gene promoter polymorphism -30G>A (rs1799884) is associated with fasting glucose in healthy pregnant women but not with gestational diabetes. Clin Chim Acta 2010;411:892-893
36. Beer NL, Tribble ND, McCulloch LJ, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 2009;18:4081-4088
37. Lovejoy J, Newby FD, Gebhart SS, DiGirolamo M. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism 1992;41:22-27